Application Perspectives of Nanomedicine in Cancer Treatment.
cancer
chemotherapy
gene therapy
immunotherapy
nanomedicine
Journal
Frontiers in pharmacology
ISSN: 1663-9812
Titre abrégé: Front Pharmacol
Pays: Switzerland
ID NLM: 101548923
Informations de publication
Date de publication:
2022
2022
Historique:
received:
31
03
2022
accepted:
16
05
2022
entrez:
21
7
2022
pubmed:
22
7
2022
medline:
22
7
2022
Statut:
epublish
Résumé
Cancer is a disease that seriously threatens human health. Based on the improvement of traditional treatment methods and the development of new treatment modes, the pattern of cancer treatment is constantly being optimized. Nanomedicine plays an important role in these evolving tumor treatment modalities. In this article, we outline the applications of nanomedicine in three important tumor-related fields: chemotherapy, gene therapy, and immunotherapy. According to the current common problems, such as poor targeting of first-line chemotherapy drugs, easy destruction of nucleic acid drugs, and common immune-related adverse events in immunotherapy, we discuss how nanomedicine can be combined with these treatment modalities, provide typical examples, and summarize the advantages brought by the application of nanomedicine.
Identifiants
pubmed: 35860027
doi: 10.3389/fphar.2022.909526
pii: 909526
pmc: PMC9291274
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
909526Informations de copyright
Copyright © 2022 Hou, Hasnat, Chen, Liu, Faran Ashraf Baig, Liu and Chen.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Proc Biol Sci. 2015 Dec 22;282(1821):20143003
pubmed: 26702034
Nat Rev Clin Oncol. 2020 Dec;17(12):725-741
pubmed: 32760014
Nano Lett. 2020 Mar 11;20(3):1578-1589
pubmed: 31951421
Cancer Lett. 2020 Jan 1;468:88-101
pubmed: 31593800
Cell Death Dis. 2020 Feb 5;11(2):92
pubmed: 32024821
Clin Cancer Res. 2020 Jan 15;26(2):477-486
pubmed: 31831565
Science. 2018 Mar 23;359(6382):1355-1360
pubmed: 29567706
J Mater Chem B. 2020 Jan 22;8(3):492-503
pubmed: 31840727
Signal Transduct Target Ther. 2020 Aug 25;5(1):166
pubmed: 32843638
Int J Nanomedicine. 2017 Apr 26;12:3375-3393
pubmed: 28490877
J Control Release. 2018 Apr 10;275:177-185
pubmed: 29474961
Curr Med Chem. 2009;16(25):3267-85
pubmed: 19548866
Nanomedicine. 2019 Aug;20:101997
pubmed: 31028889
ACS Nano. 2016 Apr 26;10(4):4184-91
pubmed: 26959856
Int J Pharm. 2020 May 15;581:119289
pubmed: 32243968
J Oncol. 2022 Mar 31;2022:8901326
pubmed: 35401745
Angew Chem Int Ed Engl. 2018 Nov 19;57(47):15486-15490
pubmed: 30288887
ACS Nano. 2017 Mar 28;11(3):2387-2392
pubmed: 28277646
Mol Cancer. 2020 Jan 24;19(1):15
pubmed: 31980023
Angew Chem Int Ed Engl. 2021 Mar 22;60(13):6890-6918
pubmed: 31729826
Drug Deliv. 2020 Dec;27(1):1156-1164
pubmed: 32755291
J Control Release. 2021 Jan 10;329:997-1022
pubmed: 33091526
Acc Chem Res. 2016 Nov 15;49(11):2540-2550
pubmed: 27797171
Adv Exp Med Biol. 2019;1174:313-329
pubmed: 31713204
J Control Release. 2020 Sep 10;325:176-190
pubmed: 32619748
Nat Rev Cancer. 2021 Jun;21(6):360-378
pubmed: 33907315
Int J Mol Sci. 2021 Apr 28;22(9):
pubmed: 33925129
Biochemistry. 2003 Dec 23;42(50):14988-93
pubmed: 14674775
Biomater Sci. 2021 Aug 7;9(15):5092-5115
pubmed: 34160488
ACS Nano. 2021 Apr 27;15(4):6645-6657
pubmed: 33787219
Nat Nanotechnol. 2017 Aug;12(8):813-820
pubmed: 28416815
Theranostics. 2019 Apr 12;9(8):2167-2182
pubmed: 31149036
Bioact Mater. 2020 Dec 26;6(7):1973-1987
pubmed: 33426371
J Control Release. 2021 Aug 10;336:410-432
pubmed: 34171445
ACS Appl Mater Interfaces. 2020 Mar 11;12(10):11307-11319
pubmed: 32048820
Int J Biol Sci. 2019 Sep 7;15(12):2548-2560
pubmed: 31754328
Adv Funct Mater. 2021 Mar 17;31(12):2008279
pubmed: 33613148
Nat Rev Cancer. 2021 May;21(5):298-312
pubmed: 33750922
Macromol Rapid Commun. 2019 Mar;40(5):e1800068
pubmed: 29708298
Semin Cancer Biol. 2021 Feb;69:307-324
pubmed: 32259643
Mol Metab. 2020 Mar;33:2-22
pubmed: 31685430
Sci Transl Med. 2019 Dec 18;11(523):
pubmed: 31852795
Life Sci. 2021 Mar 15;269:119087
pubmed: 33476633
CA Cancer J Clin. 2021 May;71(3):209-249
pubmed: 33538338
Drug Deliv. 2021 Dec;28(1):408-421
pubmed: 33594923
Chem Soc Rev. 2017 Jun 19;46(12):3808-3829
pubmed: 28489096
Mikrochim Acta. 2020 Oct 23;187(11):625
pubmed: 33095314
Front Bioeng Biotechnol. 2021 Aug 17;9:720291
pubmed: 34490226
Acta Pharmacol Sin. 2017 Jan;38(1):1-8
pubmed: 27569390
Proc Natl Acad Sci U S A. 1999 Jul 20;96(15):8420-5
pubmed: 10411890
ACS Nano. 2018 Dec 26;12(12):11740-11755
pubmed: 30508378
ACS Nano. 2017 Mar 28;11(3):2531-2544
pubmed: 28157292
Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2019 Sep;11(5):e1559
pubmed: 31172659
Asian J Pharm Sci. 2020 Sep;15(5):576-590
pubmed: 33193861
Chem Commun (Camb). 2017 Jan 3;53(3):573-576
pubmed: 27975087
Nat Protoc. 2021 Oct;16(10):4878-4896
pubmed: 34497386
Nanoscale Horiz. 2021 Sep 1;6(9):729-743
pubmed: 34323910
Acta Biomater. 2019 Sep 15;96:456-467
pubmed: 31260821
Nat Biomed Eng. 2018 Nov;2(11):850-864
pubmed: 31015614
Nat Protoc. 2015 Oct;10(10):1508-24
pubmed: 26357007
Sci Adv. 2019 Apr 03;5(4):eaav7199
pubmed: 30949579
ACS Biomater Sci Eng. 2020 Sep 14;6(9):4816-4833
pubmed: 33455214
Small. 2018 May;14(19):e1704465
pubmed: 29655306
Adv Drug Deliv Rev. 2020 Dec;167:170-188
pubmed: 32622022
Chemistry. 2020 Jun 10;26(33):7442-7450
pubmed: 32166771
Trends Biotechnol. 2019 Mar;37(3):281-293
pubmed: 30278987
Mater Today (Kidlington). 2018 Jul-Aug;21(6):673-685
pubmed: 30197553
Nat Biotechnol. 2018 Sep;36(8):707-716
pubmed: 29985479
Semin Cancer Biol. 2021 Aug;73:169-177
pubmed: 33130036
Front Pharmacol. 2018 Apr 27;9:421
pubmed: 29755355
Adv Sci (Weinh). 2018 Oct 29;5(12):1801012
pubmed: 30581704
J Immunol Res. 2020 Nov 17;2020:5825401
pubmed: 33282961
J Neurooncol. 2014 Jun;118(2):239-246
pubmed: 24756350
Biomaterials. 2014 Jan;35(1):590-600
pubmed: 24125775
Theranostics. 2017 Aug 23;7(15):3667-3689
pubmed: 29109768
Theranostics. 2021 Apr 26;11(13):6526-6541
pubmed: 33995674
Nanomedicine. 2018 Feb 17;14(4):1181-1190
pubmed: 29458213
ACS Nano. 2011 Aug 23;5(8):6156-63
pubmed: 21732610
Annu Rev Biochem. 1999;68:523-58
pubmed: 10872459
J Control Release. 2020 Jul 10;323:191-202
pubmed: 31838201
Adv Clin Chem. 2016;75:71-97
pubmed: 27346617
Angew Chem Int Ed Engl. 2021 Feb 1;60(5):2594-2598
pubmed: 33089613
Drug Resist Updat. 2017 Jan;30:39-47
pubmed: 28363334
J Hematol Oncol. 2020 Jul 2;13(1):86
pubmed: 32616000
Clin Pharmacol Ther. 2020 Jan;107(1):112-122
pubmed: 31622496
Acc Chem Res. 2020 Oct 20;53(10):2055-2067
pubmed: 32910636
ACS Appl Mater Interfaces. 2018 May 9;10(18):15418-15427
pubmed: 29676144
Transl Res. 2019 Dec;214:62-91
pubmed: 31369717
Theranostics. 2019 Apr 13;9(10):2779-2790
pubmed: 31244922
Small. 2017 Feb;13(7):
pubmed: 28005298
Acc Chem Res. 2011 Oct 18;44(10):1105-13
pubmed: 21557543
J Am Chem Soc. 2019 Mar 13;141(10):4282-4290
pubmed: 30730715
Int J Mol Sci. 2020 Mar 05;21(5):
pubmed: 32150841
Anal Chem. 2017 Apr 4;89(7):4320-4327
pubmed: 28301132
Adv Drug Deliv Rev. 2016 Nov 15;106(Pt A):116-131
pubmed: 27133387
Nanoscale. 2013 Dec 21;5(24):12278-85
pubmed: 24150593
Cancer Biol Ther. 2022 Dec 31;23(1):173-185
pubmed: 35188070
Nat Rev Mater. 2021;6(9):766-783
pubmed: 34026278
Pharmaceutics. 2022 Mar 16;14(3):
pubmed: 35336026
ACS Appl Mater Interfaces. 2018 Jan 31;10(4):3282-3294
pubmed: 29278317
Mol Pharm. 2017 Jan 3;14(1):107-123
pubmed: 27982602
Oncogene. 2015 Jan 29;34(5):589-99
pubmed: 24469052
J Drug Target. 2014 Jan;22(1):76-85
pubmed: 24093636
Acc Chem Res. 2021 Sep 7;54(17):3313-3325
pubmed: 34415728
Drug Dev Ind Pharm. 2017 Sep;43(9):1391-1401
pubmed: 28523942
Biomolecules. 2021 Dec 10;11(12):
pubmed: 34944499
Biomed Pharmacother. 2020 Apr;124:109821
pubmed: 31962285
J Adv Res. 2021 Feb 24;33:201-213
pubmed: 34603790
Biomater Sci. 2021 Nov 9;9(22):7534-7546
pubmed: 34647548
Crit Rev Anal Chem. 2021;51(5):399-410
pubmed: 32212927
Cancer Gene Ther. 2019 Nov;26(11-12):345-346
pubmed: 31285540
Adv Healthc Mater. 2021 Mar;10(6):e2002081
pubmed: 33586322
Small. 2016 Jan 20;12(3):308-20
pubmed: 26583570
Adv Colloid Interface Sci. 2017 Aug;246:13-39
pubmed: 28716187
J Control Release. 2013 Sep 28;170(3):365-72
pubmed: 23770008
Theranostics. 2020 Mar 15;10(10):4557-4588
pubmed: 32292515
Chem Soc Rev. 2021 Nov 1;50(21):11966-11978
pubmed: 34499072
Biomater Sci. 2020 Oct 7;8(19):5415-5426
pubmed: 32996920
ACS Nano. 2021 May 25;15(5):9111-9125
pubmed: 33988024
Cancers (Basel). 2022 Feb 14;14(4):
pubmed: 35205694
Front Immunol. 2021 Mar 29;12:652924
pubmed: 33854512
J Inorg Biochem. 2009 Jul;103(7):1039-44
pubmed: 19501911
ACS Nano. 2020 Nov 16;:
pubmed: 33197176
Acc Chem Res. 2018 Jan 16;51(1):127-137
pubmed: 29281244
Acta Pharm Sin B. 2018 Jan;8(1):34-50
pubmed: 29872621
Angew Chem Int Ed Engl. 2018 May 4;57(19):5389-5393
pubmed: 29569826
J Control Release. 2020 Mar 10;319:407-415
pubmed: 31923538
Biochim Biophys Acta. 2000 Nov 15;1488(3):189-210
pubmed: 11082530
Mol Cancer Ther. 2020 Mar;19(3):858-867
pubmed: 31941722
J Biomed Nanotechnol. 2012 Jun;8(3):508-14
pubmed: 22764421
Crit Rev Food Sci Nutr. 2017 Nov 22;57(17):3673-3683
pubmed: 26980693
ACS Nano. 2014 Jul 22;8(7):6633-43
pubmed: 24963790
J Control Release. 2018 Jul 28;282:140-147
pubmed: 29518467
Sci Adv. 2020 Nov 18;6(47):
pubmed: 33208369
Molecules. 2021 Oct 14;26(20):
pubmed: 34684792
Cancers (Basel). 2020 Mar 20;12(3):
pubmed: 32245016
Int J Mol Sci. 2021 Jun 04;22(11):
pubmed: 34199901
Nanoscale Res Lett. 2017 Aug 15;12(1):495
pubmed: 28812246
Semin Cancer Biol. 2019 Dec;59:66-79
pubmed: 30738865
Semin Cancer Biol. 2019 Apr;55:106-119
pubmed: 29673923
Curr Pharm Des. 2022;28(5):380-394
pubmed: 34727851
J Mater Chem B. 2021 Jan 7;9(1):94-100
pubmed: 33220661
Nat Commun. 2020 Nov 27;11(1):6080
pubmed: 33247092
Clin Chim Acta. 2018 May;480:92-98
pubmed: 29408173
Ann Surg Oncol. 2018 Oct;25(11):3404-3412
pubmed: 30039324
Chem Soc Rev. 2021 Aug 7;50(15):8669-8742
pubmed: 34156040
Nat Rev Genet. 2020 Jan;21(1):5-26
pubmed: 31636414
Adv Mater. 2021 May;33(20):e2006007
pubmed: 33792097
Talanta. 2018 Mar 1;179:356-363
pubmed: 29310244
Chem Rev. 2017 Sep 13;117(17):11476-11521
pubmed: 28862437
Theranostics. 2019 Feb 7;9(5):1247-1263
pubmed: 30867828
Nano Converg. 2019 Jul 15;6(1):23
pubmed: 31304563
ACS Nano. 2013 Jun 25;7(6):4830-7
pubmed: 23718215
Adv Drug Deliv Rev. 2018 May;130:73-89
pubmed: 30012492
Theranostics. 2021 Apr 19;11(13):6370-6392
pubmed: 33995663
Life Sci. 2002 Dec 27;72(6):677-87
pubmed: 12467908
J Inherit Metab Dis. 1988;11 Suppl 1:4-17
pubmed: 3141685
Adv Drug Deliv Rev. 2019 Jul;147:2-21
pubmed: 30769047
J Mater Chem B. 2021 Jan 28;9(3):612-633
pubmed: 33306079
Biotechnol Bioeng. 2021 Aug;118(8):2906-2922
pubmed: 34050923
Open Biol. 2018 Jun;8(6):
pubmed: 29875199
Nat Commun. 2019 Aug 28;10(1):3850
pubmed: 31462642
Theranostics. 2022 Jan 24;12(4):1800-1815
pubmed: 35198074
J Nanobiotechnology. 2021 Nov 25;19(1):389
pubmed: 34823541
ACS Nano. 2016 Jul 26;10(7):6542-51
pubmed: 27303951
Lancet. 1992 Mar 21;339(8795):715-21
pubmed: 1347590
Theranostics. 2021 Jan 1;11(2):614-648
pubmed: 33391496
Biomacromolecules. 2019 Feb 11;20(2):882-892
pubmed: 30621390
Cold Spring Harb Perspect Biol. 2010 Oct;2(10):a003236
pubmed: 20719876
Adv Sci (Weinh). 2020 Jun 13;7(14):1903381
pubmed: 32714743
Nanoscale. 2021 Jan 28;13(3):1875-1883
pubmed: 33439183
Proc Natl Acad Sci U S A. 2014 Oct 14;111(41):14900-5
pubmed: 25267615
ACS Nano. 2017 Nov 28;11(11):11127-11134
pubmed: 29028305
Biomaterials. 2021 Dec;279:121202
pubmed: 34749072
Adv Drug Deliv Rev. 2014 Feb;66:2-25
pubmed: 24270007
Angew Chem Int Ed Engl. 2019 Oct 1;58(40):14224-14228
pubmed: 31389144
Saudi Pharm J. 2014 Dec;22(6):504-15
pubmed: 25561862
Nanomaterials (Basel). 2021 Mar 08;11(3):
pubmed: 33800368
Front Immunol. 2021 Mar 17;12:607692
pubmed: 33815364
Nat Rev Drug Discov. 2019 Mar;18(3):175-196
pubmed: 30622344
J Mater Chem B. 2019 Dec 11;7(48):7639-7655
pubmed: 31746934
Biomaterials. 2020 Oct;256:120221
pubmed: 32738651
Int J Mol Sci. 2018 Sep 14;19(9):
pubmed: 30223518